Praxis Precision Medicines (PRAX) shares outstanding

Shares outstanding · fiscal 2025
22.50M

Praxis Precision Medicines (PRAX) had 22.50M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 25.7% higher than the 17.91M of fiscal 2024. Figures as of 18 Nov 2026, 12:30 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
22.50M
Change on fiscal 2024
+25.7%
Growth, 5 years
+106.7% a year
Highest on record
22.50Mfiscal 2025
Lowest on record
596.68Kfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Praxis Precision Medicines shares outstanding, in more detail

The market data feed counts 27.95M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 106.7% a year. Across the 6 fiscal years on record (2020–2025), the highest was 22.50M in fiscal 2025 and the lowest 596.68K in fiscal 2020.

History · 6 fiscal years

Shares outstanding by fiscal year

Praxis Precision Medicines shares outstanding, year by year

Praxis Precision Medicines (PRAX) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202522.50M 25.7% up
202417.91M 171.5% up
20236.59M 114.6% up
20223.07M 8.6% up
20212.83M 374.3% up
2020596.68K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Praxis Precision Medicines and comparable companies
CompanyShares outstandingFiscal year
Oscar Health OSCR262.39M2025
TG Therapeutics TGTX161.41M2025
Praxis Precision Medicines PRAX22.50M2025
Twist Bioscience TWST62.62M2026
Protagonist Therapeutics PTGX63.57M2025
Krystal Biotech KRYS29.95M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PRAX

Praxis Precision Medicines, figure by figure

Praxis Precision Medicines (PRAX) overview: price, valuation and scorecardAll health care companies by market value

Praxis Precision Medicines shares outstanding: questions and answers

How many shares does Praxis Precision Medicines have?

Praxis Precision Medicines (PRAX) had 22.50M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 25.7% higher than the 17.91M of fiscal 2024. The market data feed counts 27.95M shares outstanding today.

What is the growth rate of Praxis Precision Medicines's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 106.7% a year.

What are the highest and lowest diluted share count figures on record for Praxis Precision Medicines?

Across the 6 fiscal years on record (2020–2025), the highest was 22.50M in fiscal 2025 and the lowest 596.68K in fiscal 2020.

How is Praxis Precision Medicines's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Praxis Precision Medicines it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Praxis Precision Medicines (PRAX) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/PRAX/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.